O]ur companies have until June of 2028 to get there. That should not be a sigh of relief. That should be a, oh my gosh, we've ...

24/7 Market News encourages readers and industry observers to obtain a copy of this month’s National Geographic to review the full feature and explore the scientific context in depth. Interested ...

As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...

Sana Biotechnology Inc. (NASDAQ:SANA) is one of the most promising penny stocks under $5 to buy. On February 17, Sana ...

Apogee Therapeutics (NASDAQ: APGE) is one of the 17 biotechnology stocks with more than 50% upside. On January 25, Citi analyst Geoff Meacham maintained a Buy rating on Apogee Therapeutics ...

In an effort to battle against what members feel is an existential threat to their business, a group of 10 domestic biotech companies have launched the Midsized Biotech Alliance of America with a ...

This player's pipeline should keep growth going over the long run.

Over the past two calendar years, acquirers have agreed to pay more than $38 billion to purchase venture-backed companies in ...

The AI drug discovery specialist is the fifth biotechnology company to go public in February and priced the sector’s largest new stock offering in nearly three years.

Come to the Biotech Career & Futures Fair, where representatives of top biotech and biopharmaceutical companies will discuss their current and future job openings. The event is open to all Wake Tech ...